Modern biopharma development requires more than just a LIMS and spreadsheets. Learn why in this article by Alberto Pascual, IDBS, featuring Accenture and published in Lab Manager.
Gain key insights on the value of using purpose-built software systems to streamline your critical manufacturing data management and product quality processes across internal and external networks.
The current state of biopharma drug development is a barrier to the timely and cost-effective treatment of disease.
It’s been a busy year so far. And we’re only at the start of April! Find out what we’ve been up to in this blog.
Book your meetings with IDBS and Scitara at the IOT & Smart Pharma Summit this year in San Diego, CA. We look forward to being back in person and virtually in 2022.
IDBS will be running our annual experience event, i3, again in June this year!
IDBS will be running our annual experience event, i3, again in June this year!
Compared to most other industries, life science and biopharmaceutical companies have been slow to embrace digital technologies. Why?
As the biopharmaceutical industry begins to embrace advanced data collection and analysis tools, it finds itself facing a challenging question: How can drug manufacturers best harness all that data to improve capacity, reduce bottlenecks and cut costs?
While you may not find yourself Kitesurfing in Barbados, intuitive cell line selection unleashing powerful high throughput capabilities promises to be exhilarating.
